Device Trial Radar · NCT02844465
Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
Last checked: Nov 19, 2026Latest source record: Jan 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
167
Actual
Start
Dec 2016
Primary completion
Dec 11, 2023
Study completion Dec 11, 2023
Sponsor
- Lead sponsor
- MedtronicNeuroNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 26, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed to evaluate the safety and efficacy of the Visualase MRI-guided laser ablation system for mesial temporal epilepsy (MTLE).
Conditions
- Temporal Lobe Epilepsy
Interventions
Visualase MRI-Guided Laser AblationDevice
All subjects will undergo MRI-guided laser ablation of the amygdala and hippocampus with the Visualase System.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Qualifying Adverse EventsTime frame: 12 months
- Seizure Freedom, Defined as Engel Classification of Postoperative Outcome Class ITime frame: 12 months
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Hoag Memorial Hospital Presbyterian
Newport Beach, California
Stanford University
Palo Alto, California
University of California, San Francisco
San Francisco, California
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.